Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

BACKGROUND: Type 1 diabetes (T1D) results from immune-mediated destruction of insulin-producing beta cells. Prevention efforts have focused on immune modulation and supporting beta cell health before or around diagnosis; however, heterogeneity in disease progression and therapy response has limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Felton, Jamie L., Griffin, Kurt J., Oram, Richard A., Speake, Cate, Long, S. Alice, Onengut-Gumuscu, Suna, Rich, Stephen S., Monaco, Gabriela S. F., Evans-Molina, Carmella, DiMeglio, Linda A., Ismail, Heba M., Steck, Andrea K., Dabelea, Dana, Johnson, Randi K., Urazbayeva, Marzhan, Gitelman, Stephen, Wentworth, John M., Redondo, Maria J., Sims, Emily K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550983/
https://www.ncbi.nlm.nih.gov/pubmed/37794169
http://dx.doi.org/10.1038/s43856-023-00357-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550983/
https://www.ncbi.nlm.nih.gov/pubmed/37794169
http://dx.doi.org/10.1038/s43856-023-00357-y

Ejemplares similares